Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
Zachary K. Baldwin, Boshen Jiao, Anirban Basu, et al.
PharmacoEconomics - Open (2022) Vol. 6, Iss. 4, pp. 469-481
Open Access | Times Cited: 21

Showing 21 citing articles:

Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges
Takeya Adachi, Ayman W. El‐Hattab, Ritu Jain, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4732-4732
Open Access | Times Cited: 78
The Direct Medical Costs of Sickle Cell Disease in Saudi Arabia: Insights from a Single Center Study
Yazed AlRuthia
Healthcare (2025) Vol. 13, Iss. 4, pp. 420-420
Open Access
Determinants of knowledge, attitudes, and practice towards sickle cell disease in Alebtong district, Lango region, Northern Uganda
Agaba Peninah, Nankinga Olivia, Candia Douglas Andabati, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Economic burden of sickle cell disease in the United States: a retrospective analysis of a commercial insurance database
Giovanna Tedesco Barcelos, Telma Peixoto, José Alvir, et al.
Journal of Comparative Effectiveness Research (2025)
Open Access
Burden of employment loss and absenteeism in adults and caregivers of children with sickle cell disease
Rachel D’Amico Gordon, Rina Li Welkie, Nives Quaye, et al.
Blood Advances (2024) Vol. 8, Iss. 5, pp. 1143-1150
Open Access | Times Cited: 3
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges
Daniel L. Dexter, Patrick T. McGann
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 5, pp. 430-441
Closed Access | Times Cited: 8
Global burden of transfusion in sickle cell disease
Baba Inusa, Wale Atoyebi, Biree Andemariam, et al.
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 5, pp. 103764-103764
Open Access | Times Cited: 8
Economic Burden of Sickle Cell Disease in Saudi Arabia
Emad Shdaifat, Firas T Abu-Sneineh, Nagla Alsaleh, et al.
Value in Health Regional Issues (2024) Vol. 45, pp. 101038-101038
Open Access | Times Cited: 2
Peripheral transient receptor potential vanilloid type 4 hypersensitivity contributes to chronic sickle cell disease pain
Vanessa Ehlers, Katelyn E. Sadler, Cheryl L. Stucky
Pain (2023) Vol. 164, Iss. 8, pp. 1874-1886
Closed Access | Times Cited: 6
An integrated therapeutic approach to sickle cell disease management beyond infancy
Jean‐Antoine Ribeil, Galia Pollock, Haydar Frangoul, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1087-1096
Closed Access | Times Cited: 5
Crispr-based gene therapy for the induction of fetal hemoglobin in sickle cell disease
Meghann McManus, Haydar Frangoul, Martin H. Steinberg
Expert Review of Hematology (2024)
Closed Access | Times Cited: 1
Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
KATE JOHNSON, Boshen Jiao, M. A. Bender, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267448-e0267448
Open Access | Times Cited: 5
Sickle Cell Disease: A Global Patient Registry Review
Oktawia Borecka, Akosua Ofori, Fatemeh Amini, et al.
Future Rare Diseases (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 3
Network pharmacology and an in silico-based study to identify proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia
Lila Rosa Maturana Pérez, Johana Márquez Lázaro, Neyder Contreras Puentes, et al.
Research Square (Research Square) (2024)
Open Access
Identification of proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia by in silico study and network pharmacology
Lila Rosa Maturana Pérez, Johana Márquez Lázaro, Neyder Contreras Puentes, et al.
(2024)
Closed Access
Identification of proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia by in silico study and network pharmacology
Lila Rosa Maturana-Pérez, Johana Marquez-P, Neyder Contreras‐Puentes, et al.
Informatics in Medicine Unlocked (2024) Vol. 49, pp. 101534-101534
Open Access
Breaking Barriers to Access: Empowering Vulnerable Populations with Cell and Gene Therapy
Jennifer Goldenberg
Onco Zine - The International Oncology Network (2023)
Closed Access | Times Cited: 1
Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease
Sarah R. MacEwan, Chien‐Wei Chiang, Sarah H. O’Brien, et al.
Blood Advances (2023) Vol. 8, Iss. 1, pp. 224-233
Open Access | Times Cited: 1
Predictors of hospital readmissions in adult patients with sickle cell disease
Laura Hernandez Santiago
American Journal of Blood Research (2023) Vol. 13, Iss. 6, pp. 189-197
Open Access | Times Cited: 1
An alcohol dehydrogenase 7 gene polymorphism associates with both acute and chronic pain in sickle cell disease
Yavnika Kashyap, Ying He, Nilanjana Sadhu, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 12, pp. 641-649
Closed Access
Regional anesthesia and sickle cell crisis in pediatric patients: An educational‐focused review
Amr Elhamrawy, Giorgio Veneziano, Joseph D. Tobias
Pediatric Anesthesia (2023) Vol. 34, Iss. 3, pp. 195-203
Open Access
Page 1

Scroll to top